Date: Wednesday 13 Jul 2011
Pharmaceutical groups Sanofi and Regeneron Pharmaceuticals announced positive results from the clinical phase IIb study for Sarilumab in the treatment of rheumatoid arthritis.
No recent information was found.
| 2 Pharmecutical Concerns Are Buying Rights to Dr... | 09-Sep-2003 | New York Times |
| A Disappointing Obesity Drug Trial | 01-Apr-2003 | New York Times |
| Stocks surge on eve of election | 07-Nov-2006 | LA Times |
| Stocks: Dollar's decline makes Wall Street nervous | 20-May-2003 | Intl Herald Tribune |
| How a Side Effect Might Turn Into Success | 02-Jun-2002 | New York Times |
| Currency | US Dollars |
| Share Price | $ 132.17 |
| Change Today | $ 2.46 |
| % Change | 1.90 % |
| 52 Week High | $140.01 |
| 52 Week Low | $44.96 |
| Volume | 824,262 |
| Shares Issued | 93.03m |
| Market Cap | $12,296m |
| Beta | 0.78 |
| RiskGrade | 208 |
| Strong Buy | 8 |
| Buy | 1 |
| Neutral | 8 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Time | Volume / Share Price |
| 16:00 | 600 @ $132.17 |
| 16:00 | 3,000 @ $132.17 |
| 16:00 | 10,915 @ $132.17 |
| 15:59 | 300 @ $132.16 |
| 15:59 | 201 @ $132.15 |
You are here: research